Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
The Journal of Clinical Investigation|November 3, 2022
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patientsSixten Körper, Beate Grüner, Daniel Zickler, et al.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 7, 2025
Paediatric acute liver failure: A prospective, nationwide, population-based surveillance study in GermanyDominic Lenz, Muhammad Abdulaziz, Bianca Peters, et al.
The Lancet. Infectious Diseases|May 19, 2020
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case seriesMerle M Böhmer, Udo Buchholz, Victor M Corman, et al.
Pathogens (Basel, Switzerland)|April 28, 2023
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022Ruth Offergeld, Karina Preußel, Thomas Zeiler, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Infection|June 15, 2020
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Florian Kurth, Maria Roennefarth, Charlotte Thibeault, et al.
Plos Biology|November 16, 2022
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expressionDaniela Niemeyer, Saskia Stenzel, Talitha Veith, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Pageof 15